GUGULIPID: A Natural Cholesterol-Lowering Agent
- 1 July 2003
- journal article
- review article
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 23 (1) , 303-313
- https://doi.org/10.1146/annurev.nutr.23.011702.073102
Abstract
▪ Abstract The resin of the Commiphora mukul tree has been used in Ayurvedic medicine for more than 2000 years to treat a variety of ailments. Studies in both animal models and humans have shown that this resin, termed gum guggul, can decrease elevated lipid levels. The stereoisomers E- and Z-guggulsterone have been identified as the active agents in this resin. Recent studies have shown that these compounds are antagonist ligands for the bile acid receptor farnesoid X receptor (FXR), which is an important regulator of cholesterol homeostasis. It is likely that this effect accounts for the hypolipidemic activity of these phytosteroids.Keywords
This publication has 19 references indexed in Scilit:
- Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid ReceptorJournal of Biological Chemistry, 2001
- Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear ReceptorsMolecular Cell, 2000
- A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid BiosynthesisMolecular Cell, 2000
- A comparative study on hypocholesterolaemic effect of allicin, whole germinated seeds of bengal gram and guggulipid of gum guggluPhytotherapy Research, 2000
- Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein GeneJournal of Biological Chemistry, 1999
- Anti-Inflammatory Activity of Resins from some Species of the Plant Family BurseraceaePlanta Medica, 1993
- Effects of long-term rifampicin administration in primary biliary cirrhosisGastroenterology, 1992
- Enzyme induction with rifampicin; lipoproteins and drug binding to alpha 1‐acid glycoprotein.British Journal of Clinical Pharmacology, 1983
- Chemistry of ayurvedic crude drugs—VTetrahedron, 1982
- Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicinClinical Pharmacology & Therapeutics, 1979